Further optimization of the mGlu5 PAM clinical candidate VU0409551/JNJ-46778212: Progress and challenges towards a back-up compound
about
Preliminary investigation of 6,7-dihydropyrazolo[1,5-a]pyrazin-4-one derivatives as a novel series of mGlu5 receptor positive allosteric modulators with efficacy in preclinical models of schizophrenia.Acyl dihydropyrazolo[1,5-a]pyrimidinones as metabotropic glutamate receptor 5 positive allosteric modulators.
P2860
Further optimization of the mGlu5 PAM clinical candidate VU0409551/JNJ-46778212: Progress and challenges towards a back-up compound
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Further optimization of the mG ...... ges towards a back-up compound
@en
type
label
Further optimization of the mG ...... ges towards a back-up compound
@en
prefLabel
Further optimization of the mG ...... ges towards a back-up compound
@en
P2093
P2860
P50
P1476
Further optimization of the mG ...... ges towards a back-up compound
@en
P2093
Carlos Manuel Martínez-Viturro
Carrie K Jones
Chrysa Malosh
Claire Mackie
Gregor J Macdonald
Hilde Lavreysen
J Scott Daniels
Jesus Alcázar
José Manuel Bartolomé-Nebreda
Shaun R Stauffer
P2860
P304
P356
10.1016/J.BMCL.2015.06.096
P407
P577
2015-07-04T00:00:00Z